SMTL ID : 3r1y.1

CDK2 in complex with inhibitor KVR-1-134

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 4 residues within 4Å: Chain A: F.256, E.265, R.268, S.269 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.268 Water bridges: A:S.269

1 x X76: 2-[(pyridin-3-ylmethyl)amino]benzamide(Non-covalent)

X76.2: 10 residues within 4Å: Chain A: I.18, V.26, A.39, E.89, F.90, L.91, H.92, Q.93, K.97, L.142 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.18, A:I.18, A:V.26, A:L.142 Hydrogen bonds: A:E.89, A:L.91, A:L.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schonbrunn, E. et al., Structure-guided optimization of novel CDK2 inhibitors discovered by high-throughput screening. To be Published

Release Date

2012-08-08

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence